NHS Mounjaro Eligibility UK 2025 | Cured Pharmacy Guide

Clinically Proven UK Registered Pharmacy

Cheapest NHS Mounjaro Eligibility UK Price £124.99

Get Mounjaro at the cheapest UK price from £124.99 with £20 off your first order using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off first order using code WEIGHTLOSSNEW

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Complete UK Guide to NHS Mounjaro Access & Eligibility

Published on: June 03, 2026

Understanding NHS Mounjaro eligibility UK criteria is essential before requesting this treatment from your GP. While Mounjaro (tirzepatide) is licensed by the MHRA for weight management, NHS access remains highly restricted due to funding limitations and strict clinical criteria. At Cured Pharmacy, our UK-registered clinical team can assess your suitability for private Mounjaro prescriptions when NHS pathways are unavailable, with transparent pricing from £124.99 and discreet next-day delivery across the UK.

Current NHS Mounjaro Eligibility Criteria in the UK

The National Institute for Health and Care Excellence (NICE) has approved tirzepatide for weight management in adults with specific clinical criteria [1]. To qualify for NHS Mounjaro eligibility UK, patients typically need a BMI of 35 kg/m² or above with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, or obstructive sleep apnoea), or a BMI of 30-34.9 kg/m² with multiple comorbidities and previous unsuccessful weight loss attempts through lifestyle interventions.

However, NICE approval does not guarantee NHS availability. Individual Integrated Care Boards (ICBs) across England determine local funding decisions, meaning NHS Mounjaro eligibility UK varies significantly by region [2]. Many ICBs have placed tirzepatide on restricted formularies or require patients to meet additional criteria beyond NICE guidance, including mandatory participation in specialist weight management programmes for 6-12 months before consideration.

NHS waiting lists for specialist weight management services currently extend 12-18 months in many regions, with some areas reporting waits exceeding two years [3]. Even after assessment, patients may face further delays for prescription initiation due to budget constraints and supply prioritisation for existing patients. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), regularly advises patients that private prescription pathways offer faster access when NHS routes are unavailable or delayed.

How Mounjaro Works: The Science Behind Tirzepatide

Mounjaro contains tirzepatide, the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK [4]. This dual mechanism distinguishes it from single-pathway GLP-1 treatments like semaglutide (Wegovy) and liraglutide (Saxenda), activating two complementary hormone pathways that regulate appetite, glucose metabolism, and energy expenditure.

In the landmark SURPASS-3 clinical trial, patients receiving the 15mg maintenance dose of tirzepatide achieved an average 22.5% body weight reduction over 72 weeks — significantly greater than the 14.9% reduction observed with semaglutide 1mg in head-to-head comparisons [4][5]. The dual receptor mechanism appears to produce superior glycaemic control and weight loss outcomes compared to GLP-1-only therapies, though individual responses vary based on metabolic factors and adherence.

Tirzepatide works by slowing gastric emptying, reducing appetite through central nervous system pathways, and improving insulin sensitivity in peripheral tissues [4]. Patients typically report reduced hunger and earlier satiety within the first 2-4 weeks of treatment, with progressive weight loss continuing throughout the dose escalation period. Clinical trials demonstrated that approximately 89% of participants achieved at least 5% body weight reduction, and 55% achieved at least 20% reduction on the highest dose [5].

Mounjaro Dosing Schedule and Titration

UK prescribers initiate Mounjaro at 2.5mg once weekly for four weeks to minimise gastrointestinal side effects, then increase to 5mg weekly [1]. Dose escalation continues in 2.5mg increments every four weeks based on individual tolerance and response, with maintenance doses ranging from 5mg to 15mg weekly. Your prescriber will determine the optimal dose during ongoing clinical reviews, which are required every 12 weeks for private prescriptions and typically every 6-8 weeks for NHS patients where available.

Why NHS Mounjaro Access Remains Limited Across the UK

Despite NICE approval, NHS Mounjaro eligibility UK remains constrained by three primary factors: budget impact assessments, supply chain prioritisation, and regional commissioning decisions [2]. The annual cost of tirzepatide treatment through NHS pathways ranges from £135.00-£135.00 per patient depending on maintenance dose, representing a significant financial commitment for cash-constrained ICBs managing competing clinical priorities.

Many ICBs have implemented additional gatekeeping criteria beyond NICE guidance, requiring patients to demonstrate documented failure of at least two previous weight loss interventions, participation in tier 3 specialist weight management services, and psychological assessment before Mounjaro prescription consideration [3]. These additional requirements effectively exclude patients who meet NICE criteria but cannot access specialist services due to capacity constraints or geographical limitations.

Supply prioritisation further complicates NHS access. During periods of manufacturing constraints or increased demand, NHS England directs available Mounjaro stock toward existing patients and those with the highest clinical need (typically BMI >40 kg/m² with multiple severe comorbidities) [2]. New patient initiations may be paused entirely during supply constraints, leaving eligible patients without access despite meeting all clinical criteria.

Regional Variation in NHS Mounjaro Availability

NHS Mounjaro eligibility UK differs substantially between ICB regions. Some areas in London and the South East have established clear referral pathways through tier 3 weight management services, whilst others in the Midlands and North have placed tirzepatide on 'red list' formularies requiring exceptional funding applications for each individual patient [3]. Patients should contact their local ICB medicines optimisation team to understand specific regional criteria and expected waiting times before requesting NHS Mounjaro from their GP.

Access Route Eligibility Criteria Typical Waiting Time Monthly Cost
NHS Mounjaro BMI ≥35 + comorbidities, tier 3 programme completion, ICB approval 12-24+ months (regional variation) Free (if approved)
Private Mounjaro (Cured Pharmacy) BMI ≥30 (or ≥27 with comorbidities), prescriber assessment Same-day prescription, next-day delivery From £124.99
Private Wegovy (Cured Pharmacy) BMI ≥30 (or ≥27 with comorbidities), prescriber assessment Same-day prescription, next-day delivery From £69.00
Private Saxenda (Cured Pharmacy) BMI ≥30 (or ≥27 with comorbidities), prescriber assessment Same-day prescription, next-day delivery From £68.00

Private Mounjaro Prescriptions: Eligibility and Process at Cured Pharmacy

When NHS Mounjaro eligibility UK criteria cannot be met or waiting times are prohibitive, private prescription pathways offer an alternative route to treatment. At Cured Pharmacy, our UK-registered prescribers assess patients using the same clinical criteria as NHS guidelines but without regional funding restrictions or mandatory waiting periods. Private eligibility requires a BMI of 30 kg/m² or above (or 27 kg/m² with weight-related comorbidities), commitment to lifestyle modification, and absence of contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Our online consultation process takes under three minutes and includes comprehensive medical history review, current medication screening for interactions, and cardiovascular risk assessment. A UK-registered prescriber reviews every consultation individually — we never use automated approval systems. If Mounjaro is deemed clinically appropriate, your prescription is issued the same day and dispensed from our GPhC-registered pharmacy (registration 9012511) with discreet next-day delivery across the UK.

Private Mounjaro prescriptions at Cured Pharmacy start from £124.99 per month for the 2.5mg starter dose, with transparent upfront pricing displayed before consultation. This represents competitive UK pricing compared to typical market rates, with no hidden consultation fees or membership charges. All patients receive ongoing clinical support, with prescribers available for dose adjustments and side effect management throughout treatment. Follow-up consultations are required every 12 weeks to ensure continued safety and efficacy, in line with MHRA prescribing guidance for long-term weight management medications.

Mounjaro vs Alternative Weight Loss Treatments Available in the UK

Patients who don't meet NHS Mounjaro eligibility UK criteria or prefer different treatment options have several MHRA-licensed alternatives. Wegovy (semaglutide) is a once-weekly GLP-1 injection that demonstrated 14.9% average weight loss over 68 weeks in the STEP-1 trial [5]. Whilst tirzepatide shows superior efficacy in head-to-head trials, semaglutide remains highly effective and may be preferred by patients with previous GLP-1 experience or specific tolerability considerations.

Saxenda (liraglutide) is a daily GLP-1 injection that achieved 8% average weight loss over 56 weeks in clinical trials [6]. The daily administration requires more frequent injections but allows for easier dose titration and may suit patients who prefer smaller, more frequent doses rather than higher weekly doses. Saxenda has the longest post-marketing safety data of any GLP-1 weight loss treatment, with over a decade of real-world use informing its risk-benefit profile.

Oral treatments like Orlistat (available as prescription 120mg or over-the-counter 60mg formulations) work through fat absorption inhibition rather than appetite regulation, producing approximately 3-5% weight loss when combined with reduced-calorie diets [7]. Whilst less effective than injectable GLP-1 treatments, Orlistat may be appropriate for patients with needle phobia, lower BMI ranges, or contraindications to GLP-1 therapies. Your UK prescriber will recommend the most suitable option based on your individual clinical profile, preferences, and treatment goals.

Combination Approaches and Treatment Sequencing

Some patients benefit from sequential treatment approaches, starting with oral medications or lower-intensity interventions before progressing to GLP-1 therapies if initial responses are inadequate [8]. This stepped approach mirrors NHS treatment pathways and may be cost-effective for patients funding private treatment. Our clinical team can advise on appropriate treatment sequencing during your consultation, ensuring you receive the most suitable intervention for your current stage of weight management.

Managing Side Effects and Maximising Mounjaro Treatment Success

The most common side effects of Mounjaro are gastrointestinal, including nausea (reported by 25-30% of patients), diarrhoea, constipation, and abdominal discomfort, typically most pronounced during dose escalation phases [4]. These effects usually diminish within 4-8 weeks as the body adapts to each new dose level. Our prescribers recommend eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated to minimise gastrointestinal symptoms.

Hypoglycaemia risk remains low with Mounjaro monotherapy in patients without diabetes, but increases when combined with insulin or sulfonylureas [1]. Patients with type 2 diabetes should discuss dose adjustments of existing diabetes medications with their prescriber before starting tirzepatide. Regular blood glucose monitoring is recommended during the first 12 weeks of treatment for all patients with diabetes or prediabetes.

Optimising treatment outcomes requires commitment to sustainable lifestyle modifications alongside pharmacotherapy. Clinical trials demonstrating 20%+ weight loss included structured dietary counselling and physical activity programmes [5]. Patients should aim for a 500-750 calorie daily deficit through balanced nutrition, incorporate 150+ minutes of moderate-intensity activity weekly, and attend all scheduled follow-up consultations. Our clinical team provides evidence-based lifestyle guidance during consultations and can recommend additional support resources when needed. Treatment duration typically extends 12-24 months for optimal results, with ongoing maintenance therapy often required to prevent weight regain after discontinuation [8].

When to Contact Your Prescriber During Treatment

Seek immediate medical advice if you experience severe abdominal pain (particularly if radiating to the back), persistent vomiting preventing fluid intake, signs of pancreatitis, or symptoms of thyroid nodules such as neck swelling or difficulty swallowing [1]. Contact your prescriber before your next scheduled review if side effects are significantly impacting quality of life, if you're experiencing inadequate weight loss after 16 weeks at therapeutic doses, or if you have questions about dose adjustments. Our clinical team at Cured Pharmacy remains available throughout your treatment journey for safety monitoring and optimisation support.

Scientific References

  1. Electronic Medicines Compendium. (2024). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14881 [accessed 13 August 2026]
  2. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating overweight and obesity [TA1007]. NICE. Retrieved from https://www.nice.org.uk/guidance/ta1007 [accessed 13 August 2026]
  3. Royal College of Physicians. (2024). Specialist weight management services in England: Capacity and demand analysis. RCP Policy Report. Retrieved from https://www.rcplondon.ac.uk/ [accessed 13 August 2026]
  4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  5. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  6. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11-22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
  7. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155-161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
  8. Garvey, W. T., Mechanick, J. I., Brett, E. M., et al. (2016). American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice, 22(Suppl 3), 1-203. https://doi.org/10.4158/EP161365.GL [accessed 13 August 2026]
  9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is a prescription-only medicine and individual results may vary. Weight loss outcomes depend on adherence to treatment and lifestyle modifications.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What is the BMI requirement for NHS Mounjaro eligibility UK?
NHS Mounjaro eligibility UK typically requires a BMI of 35 kg/m² or above with weight-related comorbidities, or BMI 30-34.9 kg/m² with multiple comorbidities, though individual ICBs may impose additional criteria beyond NICE guidance.
How long are NHS waiting lists for Mounjaro in the UK?
NHS waiting times for Mounjaro vary by region but typically range from 12-24 months, including referral to tier 3 weight management services, assessment, and prescription initiation, with some areas reporting longer delays due to capacity constraints.
Can I get Mounjaro privately if I don't meet NHS Mounjaro eligibility UK criteria?
Yes, private prescribers can assess you using clinical criteria that may differ from NHS restrictions. At Cured Pharmacy, patients with BMI ≥30 kg/m² (or ≥27 kg/m² with comorbidities) may be suitable for private Mounjaro prescriptions subject to individual clinical assessment.
How much does private Mounjaro cost in the UK?
Private Mounjaro prescriptions at Cured Pharmacy start from £124.99 per month for starter doses, with transparent upfront pricing and no hidden consultation fees. Final cost depends on your prescribed maintenance dose determined by your UK prescriber.
Do I need to see my GP before getting private Mounjaro?
No, you do not need a GP referral for private Mounjaro prescriptions. Our UK-registered prescribers conduct independent clinical assessments through our online consultation, though we recommend informing your GP when starting any new long-term medication.
Is Mounjaro more effective than Wegovy for weight loss?
Clinical trials show tirzepatide (Mounjaro) produced greater average weight loss than semaglutide (Wegovy) in head-to-head comparisons, with 22.5% vs 14.9% body weight reduction respectively, though individual responses vary.
What happens if I don't meet NHS Mounjaro eligibility UK criteria but my GP recommended it?
Your GP can recommend Mounjaro, but NHS funding requires ICB approval based on local criteria. If NHS access is unavailable, private prescription pathways offer an alternative route to treatment with faster access and the same medication quality.
How quickly can I start Mounjaro through Cured Pharmacy?
If clinically appropriate after prescriber review, your Mounjaro prescription is issued the same day with discreet next-day delivery across the UK. Our online consultation takes under three minutes, with most patients receiving treatment within 24-48 hours of assessment.
What is the NHS Mounjaro eligibility criteria in the UK?
To qualify for Mounjaro on the NHS, you must have a BMI of 35 or above and at least one weight-related health condition, or be part of a specialist weight management service. However, NHS availability is extremely limited, so most people buy Mounjaro privately through Cured Pharmacy for faster access.
Can I buy Mounjaro privately if I don't meet NHS eligibility?
Yes, you can buy Mounjaro privately through Cured Pharmacy even if you don't meet NHS Mounjaro eligibility requirements. Our UK-registered prescribers assess your suitability based on private prescribing guidelines, making treatment accessible to more people at the cheapest UK price from £124.99.
How long is the NHS waiting list for Mounjaro compared to private?
NHS waiting lists for Mounjaro can be 12-24 months or longer due to limited funding and strict eligibility criteria. With Cured Pharmacy, you can start treatment within 24-48 hours after completing a simple online consultation, avoiding the lengthy NHS wait entirely.
Is Mounjaro price the same across all UK pharmacies?
No, Mounjaro prices vary significantly between UK pharmacies, with some charging over £200 for the starting dose. Cured Pharmacy offers the cheapest UK price from £124.99 for 2.5mg, with an additional £20 off your first order using code Weightlossnew.
Does buying Mounjaro privately affect my NHS medical records?
Private Mounjaro prescriptions from Cured Pharmacy are separate from NHS records, though we recommend informing your GP about any private treatment. Our UK-registered prescribers maintain full confidentiality while ensuring your treatment is safe and appropriate for your health circumstances.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.